Hirtle Callaghan & Co’s Express Scripts Holding Company ESRX Stock Holding History

Hirtle Callaghan & Co’s Portfolio ESRX Stock Details ESRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-600	Closed	-$42K	–	210
2016 Q3	$42K	Buy	+600	New	+$44.9K	0.01%	145
2015 Q1	–	Sell	-1,480	Closed	-$125K	–	429
2014 Q4	$125K	Hold	1,480	–	–	0.03%	221
2014 Q3	$105K	Sell	1,480 -3,800	-72%	-$271K	0.02%	237
2014 Q2	$366K	Buy	5,280 +3,800	+257%	+$267K	0.05%	174
2014 Q1	$111K	Buy	1,480 +650	+78%	+$48.7K	0.02%	279
2013 Q4	$58K	Hold	830	–	–	0.01%	317
2013 Q3	$51K	Buy	830 +119	+17%	+$7.7K	0.01%	342
2013 Q2	$44K	Buy	+711	New	+$42.8K	0.51%	37

Other funds holding ESRX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Hirtle Callaghan & Co's ESRX Position: Q4 2016 in Review

Hirtle Callaghan & Co sold out of Express Scripts Holding Company (ESRX) in Q4 2016, closing a stake of 600 shares — an estimated $42K sold.

Hirtle Callaghan & Co first reported a position in ESRX in Q2 2013 and held it in 8 quarters. The position peaked at $366K in Q2 2014. 1,151 funds tracked by Wall St. Rank hold ESRX as of Q4 2016.

Hirtle Callaghan & Co reported no remaining Express Scripts Holding Company position as of Q4 2016 after selling out during the quarter.
Hirtle Callaghan & Co sold 600 Express Scripts Holding Company shares in Q4 2016, an estimated $42K.
Hirtle Callaghan & Co first reported a position in Express Scripts Holding Company in Q2 2013 and held it in 8 quarters.
Hirtle Callaghan & Co's Express Scripts Holding Company position peaked at $366K in Q2 2014.
1,151 funds tracked by Wall St. Rank held Express Scripts Holding Company as of Q4 2016.

Based on Hirtle Callaghan & Co's 13F filing for Q4 2016, filed 31 Jan 2017.